Back
GH Research PLC Vs. Iterum Therapeutics PLC Industry Stock Comparison
Buy
71
GHRS
GH Research PLC
Last Price:
12.50
Seasonality Move:
24.15%
Buy
52
ITRM
Iterum Therapeutics PLC
Last Price:
1.37
Seasonality Move:
-17.48%
Buy
71
GH Research PLC (GHRS)
is a Buy
Is GH Research PLC a Buy, Sell or Hold?
- The current GH Research PLC [GHRS] share price is $12.60. The Score for GHRS is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- GHRS is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
52
Iterum Therapeutics PLC (ITRM)
is a Buy
Is Iterum Therapeutics PLC a Buy, Sell or Hold?
- The current Iterum Therapeutics PLC [ITRM] share price is $1.41. The Score for ITRM is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- ITRM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
GHRS Stock Price Chart
What is GH Research PLC's stock price today?
-
The GH Research PLC share price today is $12.60
The current trend is moderately bullish and GHRS is experiencing slight selling pressure.
ITRM Stock Price Chart
What is Iterum Therapeutics PLC's stock price today?
-
The Iterum Therapeutics PLC share price today is $1.41
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITRM is experiencing slight selling pressure.
GHRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.53 | Buy |
| Relative Strength Index (14 RSI): | 61.99 | Buy |
| Chaikin Money Flow: | -8294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.94 - 12.48) | Buy |
| Bollinger Bands (100): | (6.79 - 11.41) | Buy |
ITRM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 38.17 | Sell |
| Chaikin Money Flow: | -72819 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.47 - 1.61) | Sell |
| Bollinger Bands (100): | (1.42 - 1.82) | Sell |
GHRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.6 | Buy |
| 20-day SMA: | 11.84 | Buy |
| 50-day SMA: | 11.15 | Buy |
| 200-day SMA: | 8.88 | Buy |
| 8-day EMA: | 12.53 | Buy |
| 20-day EMA: | 12.02 | Buy |
| 50-day EMA: | 11.03 | Buy |
| 200-day EMA: | 9.56 | Buy |
ITRM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.52 | Sell |
| 20-day SMA: | 1.55 | Sell |
| 50-day SMA: | 1.57 | Sell |
| 200-day SMA: | 1.34 | Buy |
| 8-day EMA: | 1.5 | Sell |
| 20-day EMA: | 1.54 | Sell |
| 50-day EMA: | 1.55 | Sell |
| 200-day EMA: | 1.49 | Sell |
GH Research PLC Earnings Growth & GHRS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.12 per share, and a decrease next year of $0.31 per share.
Iterum Therapeutics PLC Earnings Growth & ITRM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.94 per share, and an increase next year of $0.33 per share.
GH Research PLC Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Iterum Therapeutics PLC Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||